Artificial Intelligence – hype, hope or happening?
PrecisionLife CEO Dr Steve Gardner attended Pharma Integrates on 17 November to participate in the panel discussion: Artificial Intelligence – hype, hope or happening? Watch the session recording above.
AI is being applied to drug discovery, development, diagnosis and supply chains. The Artificial Intelligence panel assessed how successful has it been so far and discussed what the future holds for AI in drug discovery.
Panelists:
- Steve Gardner, Chief Executive Officer, PrecisionLife
- Jessica Morley, Director of Policy, Bennett Institute for Applied Data Science, University of Oxford
- Raminderpal Singh, Chief Executive Officer, Incubate.bio
- Beth Fordham, Operations Director, White Swan
- Ajay Mistry, Chief Executive Officer, Oppilotech
For more information, visit the Pharma Integrates website.
